Stay updated with breaking news from Yu qingming. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
鱼用配合饲料投喂技术-实用技术-农博数据中心 aweb.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aweb.com.cn Daily Mail and Mail on Sunday newspapers.
share Print China s Sinopharm is poised to play an increasingly greater role in bolstering global fight against COVID-19 with vaccines assistance worldwide, particularly among the developing countries, following the approval for use by the World Health Organization (WHO), said Shao Yiming, a researcher at the Chinese Center for Disease Control and Prevention, on Friday. The WHO validated on Friday the COVID-19 vaccine developed by China s Sinopharm for emergency use, making it the sixth vaccine to receive WHO validation on account of its safety, efficacy and quality. This makes it the first Chinese vaccine that has been officially recognized by the WHO, which also means that the China vaccine can play a greater role in the global fight against the epidemic, Shao said. ....
2021-05-08 02:19:47 GMT2021-05-08 10:19:47(Beijing Time) Xinhua English A Palestinian man receives the second dose of Chinese Sinopharm COVID-19 vaccine at a medical center during a vaccination campaign in the West Bank city of Bethlehem, April 29, 2021. (Photo by Luay Sababa/Xinhua) GENEVA, May 7 (Xinhua) The World Health Organization (WHO) validated on Friday the COVID-19 vaccine developed by China s Sinopharm for emergency use, a move set to boost global vaccine rollout, particularly in the developing world. This afternoon, the WHO gave emergency use listing to Sinopharm Beijing s COVID-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality, said WHO Director General Dr. Tedros Adhanom Ghebreyesus at a press briefing. ....
Source: China State Council Information Office The World Health Organization (WHO) validated on Friday the COVID-19 vaccine developed by Chinaâs Sinopharm for emergency use, a move set to boost global vaccine rollout, particularly in the developing world. âThis afternoon, the WHO gave emergency use listing to Sinopharm Beijingâs COVID-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality,â said WHO Director General Dr. Tedros Adhanom Ghebreyesus at a press briefing. âThis expands the list of vaccines that COVAX can buy and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine,â he said. ....
A Palestinian man receives the second dose of Chinese Sinopharm COVID-19 vaccine at a medical center during a vaccination campaign in the West Bank city of Bethlehem, April 29, 2021. (Photo by Luay Sababa/Xinhua) With the WHO s validation for emergency use, the Sinopharm vaccine, as the first COVID-19 vaccine developed by a non-western country, is expected to accelerate vaccine rollout in many low and middle-income countries through purchase and delivery by the WHO-led COVAX initiative. GENEVA, May 7 (Xinhua) The World Health Organization (WHO) validated on Friday the COVID-19 vaccine developed by China s Sinopharm for emergency use, a move set to boost global vaccine rollout, particularly in the developing world. ....